BOPA 2020 Symposium MAJOR ANNOUNCEMENT 

The BOPA Executive Committee are very excited to announce that we have secured a one-off deal to provide FREE access to all paid BOPA members* for the virtual BOPA conference 2020.

We understand that this year has brought extraordinary challenges for us all and we think it has never been more important for us to network and support each other as a community. In addition, the virtual format of the conference offers a more convenient option for those that may ordinarily struggle to attend a face to face conference due to practical commitments such as funding, travel, study leave, time away from family etc. We are in the unique position of being able to ensure that everyone who would like to attend the conference this year, can. Therefore the BOPA Executive Committee voted unanimously in support of funding places for all registered BOPA members to attend. You can attend all or part of the conference, with access to any sessions missed included as part of your registration.

The new registration form will be available in early September and we will email out the details as soon as this is live. In the meantime please contact us if you have any queries using our contact us form.

Please note: For those who have already registered and paid, the conference team will be in touch to arrange a full refund.

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article